Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Regeneron said it began late-stage clinical trials to assess the effectiveness of its antibody cocktail.
Monday, July 6, 2020
Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Regeneron said it began late-stage clinical trials to assess the effectiveness of its antibody cocktail.
0 comments:
Post a Comment